Search - tctmd.com

Displaying 541 - 558 of 558

Sort: Relevancy | Date

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

May 27, 2011

News Conference News

RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose

May 18, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

May 05, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

April 21, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

March 09, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

News Daily News

Early GPI More Effective When Paired with Upstream Clopidogrel in NSTE ACS

February 10, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

January 25, 2011

News Daily News

PROSPECT Published: Combined IVUS Identifies Risky Nonculprit ACS Lesions

January 18, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

January 10, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

January 09, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

January 03, 2011

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.